Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Why is everyone talking about Paul Dano? George Clooney becomes the actor's latest defender in this 'time of cruelty.'- Jillian Michaels put me at the center of a body positivity debate. She's not entirely wrong about obesity.
- Nick Reiner's defense attorney asks to be replaced, again delaying arraignment in connection with the stabbing deaths of his parents, Rob Reiner and Michele Singer Reiner
- How a toxic self-improvement trend with a funny name took over your feed
- Exploring the School Application Cycle: Understudy Bits of knowledge
- Involved Vehicles for Seniors: Track down the Best Picks for Solace and Dependability
- Study casts doubt on potential for life on Jupiter's moon Europa
- The most effective method to Shake Hands Expertly: A Bit by bit Guide
- The Electric Bicycle Americans Can Confide in 2024
